Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial
Fellström, Bengt C, Barratt, Jonathan, Cook, Heather, Coppo, Rosanna, Feehally, John, de Fijter, Johan W, Floege, Jürgen, Hetzel, Gerd, Jardine, Alan G, Locatelli, Francesco, Maes, Bart D, Mercer, AleLangue:
english
Journal:
The Lancet
DOI:
10.1016/S0140-6736(17)30550-0
Date:
March, 2017
Fichier:
PDF, 614 KB
english, 2017